Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07512427
PHASE1/PHASE2

Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants

Sponsor: OPKO Health, Inc.

View on ClinicalTrials.gov

Summary

Two-part Phase 1/2 study of OPK-88006, including an open-label SAD phase in healthy participants and a double-blind, randomized, placebo-controlled MAD phase in participants with presumed MASH, to evaluate safety, PK, and MASH related pharmacodynamic changes compared to placebo.

Official title: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of OPK-88006 in Healthy and Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH) Participants

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-12

Completion Date

2027-12

Last Updated

2026-04-06

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

OPK-88006

Administered by subcutaneous injection

DRUG

Placebo

Administered by subcutaneous injection